Navigation Links
Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference
Date:2/19/2008

RALEIGH, N.C., Feb. 19 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that executives from its Brand Management and Managed Markets practices will present at the 4th Annual Forum on Early Stage Product Development and Commercialization Strategies for the Bio/Pharmaceutical Industry hosted by the Center for Business Intelligence (CBI). The conference will be held February 25-26, 2008, at the Doubletree Hotel in Philadelphia, Pennsylvania.

Tom Luginbill, Vice President, and Philip Vorhies, Practice Executive, of the firm's Brand Management practice will present a workshop titled "Comprehensive Commercial Planning for Product Launch" at 3:30 pm on February 25. They will provide a comprehensive understanding of each stage of pre- launch commercial planning and identify the key deliverables for each stage. They will also discuss strategies for managing the logistics of a launch. In addition, the workshop will feature an interactive working session, during which delegates will collaborate to determine the timing of each commercial planning stage and logistics-related activity during this critical phase of a product's life cycle.

Tom Luginbill currently leads the Brand Management practice's Central region operations, but he has spent the majority of his career in the industry. In the course of his 20-year career, he has had a wide variety of commercial roles, including Sales Representative, Marketing Director, and Regional Sales Director. He also served as the Vice President of Commercial Strategy at GlaxoSmithKline, where he was responsible for the worldwide commercial development of the company's antibiotic portfolio.

Philip Vorhies brings years of experience in the pharmaceutical industry and management consulting to his work with Campbell Alliance. Mr. Vorhies has in-depth experience with launch management, life cycle planning, and commercial strategy development in multiple therapeutic areas, with specific expertise in the senior care environment.

On the second day of the conference, Kevin Barnett, Senior Vice President, will present a session titled "Early Considerations for Building Your Product's Value Proposition for Payers" at 10:15 am. Mr. Barnett's session will discuss how to apply a strategic framework for developing a payer value proposition in a rapidly evolving reimbursement environment.

As head of the firm's Managed Markets practice, Mr. Barnett is an expert at developing successful strategies that address access, pricing, marketing, and policy concerns for many of the world's leading pharmaceutical and biotech companies. During the span of his career, he has held positions at two management consulting firms as well as various commercial roles at The Upjohn Company. In recent years, Mr. Barnett has been working closely with companies to help understand and prepare for the implications of the Medicare Modernization Act.

For more information on CBI's Forum on Early Stage Product Development and Commercialization Strategies, please visit http://www.cbinet.com/show_conference.cfm?confCode=PC08026&field=summary

Executives from Campbell Alliance speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.

About the Brand Management Practice at Campbell Alliance

The Brand Management practice at Campbell Alliance can help enhance the commercial performance of products from initial launch through product maturity. The firm's team members are experts at new product planning, commercial strategy development, brand planning, product launch, and myriad other aspects of maximizing the value of pharmaceutical assets. The team has also developed commercial strategies and programs in various geographic markets, including the US, Canada, Europe, and Latin America. Services include

-- Portfolio planning

-- New product planning

-- Launch excellence

-- Growth maximization

-- Life cycle extension

-- Capability enhancement

About the Managed Markets Practice at Campbell Alliance

The Managed Markets practice at Campbell Alliance helps clients stay informed about changing conditions affecting the reimbursement and access landscape, understand the implications of these trends, and deal more effectively with third-party payers. Services include

-- Market assessments utilizing quantitative and qualitative research and

analysis as well as decision-support modeling and scenario planning

-- Strategy development for key managed markets channels such as the

creation of value propositions and pricing and contracting strategies

-- Tactical execution including account segmentation and prioritization

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
2. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
3. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Named Best Place to Work by Triangle Business Journal
6. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
7. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
8. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
9. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
10. HOYA ConBio and The Hornbrook Group Announce Expanded Alliance
11. Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ - The University of Missouri ... a business of Sterigenics International, and General Atomics (GA), ... submitted to the U.S. Nuclear Regulatory Commission (NRC). This ... of molybdenum-99 (Mo-99). Once operational, production from this facility ... demand for Mo-99, which currently must be imported from ...
(Date:3/29/2017)... The Global Microfluidic Chips Market by Manufacturers, ... and comprehensive study on the existing state of the global Microfluidic ... Europe and Asia-Pacific , ... and Africa . ... Browse 172 Tables and Figures, 13 Major Company ...
(Date:3/28/2017)... ... , ... Mass spectrometry is becoming more widely for clinical testing and evaluation ... potential to perform challenging analyses in complex matrices and sample types. While mass spectrometry ... it to be routinely used for medical testing. , In this webinar, ...
(Date:3/28/2017)... Ann Arbor, Michigan (PRWEB) , ... March 28, ... ... company was awarded a Phase II Small Business Innovation Research (SBIR) grant from ... will receive approximately $750,000 over two years to develop a suite of BioGel™ ...
Breaking Biology Technology:
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
Breaking Biology News(10 mins):